# NFAT5

## Overview
The NFAT5 gene encodes the nuclear factor of activated T cells 5, a transcription factor that plays a pivotal role in cellular adaptation to osmotic stress. This protein is distinct within the NFAT family due to its ability to function independently of calcineurin, a phosphatase required by other NFAT proteins for activation. NFAT5 is primarily involved in the regulation of osmoprotective genes, facilitating cellular homeostasis under hypertonic conditions by promoting the accumulation of organic osmolytes. Structurally, NFAT5 is characterized by a Rel-like DNA-binding domain and functions as a homodimer, with its activity modulated by post-translational modifications such as phosphorylation. Beyond its role in osmoregulation, NFAT5 is implicated in immune regulation, influencing T cell activation and inflammatory responses, and is expressed in various tissues, including the thymus. Its involvement in diverse physiological and pathological processes, such as immune function, cancer progression, and cardiovascular diseases, underscores its clinical significance (Lee2019Role; López-Rodríguez1999NFAT5; Kumar2020NFAT5).

## Structure
The NFAT5 protein, also known as the osmoprotective transcription factor, is characterized by several distinct structural features. It has an open reading frame of 4,365 base pairs, encoding a protein of 1,455 amino acids (López-Rodríguez1999NFAT5). The N-terminal domain (NTD) of NFAT5, comprising amino acids 2-220, is intrinsically disordered, with more than 75% of its sequence in a random coil configuration. This domain can undergo disorder-to-order transitions upon binding to partner proteins, influenced by osmolytes like trehalose and sorbitol (Kumar2020NFAT5). The C-terminal region is long and glutamine-rich, showing no sequence similarity to other NFAT family members (López-Rodríguez1999NFAT5).

NFAT5 contains a Rel-like DNA-binding domain, similar to other NFAT proteins, but lacks the majority of Fos/Jun contact residues, which affects its cooperative binding with these proteins (López-Rodríguez1999NFAT5). The protein functions as a homodimer, with dimerization occurring at the C-terminal region, which is crucial for its activation (Timucin2021Structure). NFAT5 is also subject to post-translational modifications, such as phosphorylation, which regulate its localization and activity (DuMond2016Peptide).

## Function
NFAT5, also known as the nuclear factor of activated T cells 5, is a transcription factor that plays a critical role in cellular adaptation to osmotic stress. It is primarily involved in regulating the expression of osmoprotective genes, which help cells maintain homeostasis under hypertonic conditions by accumulating organic osmolytes such as sorbitol, myo-inositol, betaine, and taurine (LópezRodríguez2004Loss; Kumar2020NFAT5). These osmolytes are crucial for maintaining cell volume and protecting against osmotic stress, particularly in the kidney medulla, where NFAT5 is highly expressed (LópezRodríguez2004Loss).

NFAT5 functions by binding to tonicity-responsive enhancer (TonE) sequences in the promoters of target genes, stimulating their transcription (Neuhofer2010Role). Unlike other members of the NFAT family, NFAT5 does not require calcineurin for its activation and can form homodimers to bind DNA (Lee2019Role). It is activated by hypertonic stress, which induces structural changes in its intrinsically disordered regions, enhancing its ability to interact with other proteins and regulate gene expression (Kumar2020NFAT5).

In addition to its role in osmotic stress response, NFAT5 is involved in immune regulation, influencing T cell activation and survival, and modulating inflammatory responses (Lee2019Role; Aramburu2019Regulation). It is expressed in various tissues, including the thymus, where it is most abundant, and plays a role in the development and function of the immune system (Lee2019Role).

## Clinical Significance
The NFAT5 gene is implicated in various diseases due to its role in immune regulation and response to osmotic stress. In Type 1 Diabetes (T1D), NFAT5 contributes to hyperglycemia-induced oxidative stress and diabetic complications such as retinopathy through the regulation of aldose reductase (AR) expression. NFAT5 deficiency can alleviate these conditions, highlighting its potential as a therapeutic target (Lee2019Role). In Multiple Sclerosis (MS), NFAT5 exacerbates disease progression by promoting IL-17-producing T cells in high salt conditions (Lee2019Role).

NFAT5 is also involved in cancer progression. In pancreatic ductal adenocarcinoma (PDAC), high NFAT5 expression correlates with poor prognosis and promotes tumor growth by enhancing the Warburg effect, a metabolic reprogramming that supports cancer cell proliferation (Jiang2019Transcription). In adrenocortical carcinoma (ACC), NFAT5 is frequently amplified, suggesting its role in tumor pathogenesis (Brown2020Recurrent).

In cardiovascular diseases, NFAT5 contributes to hypertension and atherosclerosis by regulating vascular smooth muscle cell proliferation and migration, as well as macrophage infiltration into atherosclerotic lesions (Zhao2021NFAT5Mediated). These findings underscore the clinical significance of NFAT5 in various pathological conditions.

## Interactions
NFAT5, also known as TonEBP/OREBP, is involved in various protein interactions that regulate its activity under osmotic stress conditions. One significant interaction is with the kinase c-Abl, which phosphorylates NFAT5 at tyrosine-143, a modification essential for its activation and interaction with phospholipase C-γ1 (PLC-γ1). This interaction enhances NFAT5's nuclear localization and transcriptional activity, crucial for cell survival in high NaCl environments (Gallazzini2010c‐Abl).

NFAT5 also interacts with TAZ, a protein that suppresses NFAT5 activity through tyrosine phosphorylation. This interaction is dependent on the phosphorylation state of TAZ, specifically at tyrosine 316, which is mediated by c-Abl. The phosphorylated TAZ can bind to NFAT5, reducing its DNA-binding and transcriptional activities (Jang2012TAZ).

Additionally, NFAT5 is part of complex protein interaction networks, as identified through peptide affinity analysis. This analysis revealed numerous proteins interacting with NFAT5's NH2-terminal and COOH-terminal regions, suggesting its involvement in multiprotein complexes that regulate transcription and signal transduction processes (DuMond2016Peptide). These interactions highlight NFAT5's role in cellular osmoregulation and its regulation by various kinases and phosphatases.


## References


[1. (Lee2019Role) Naeun Lee, Donghyun Kim, and Wan-Uk Kim. Role of nfat5 in the immune system and pathogenesis of autoimmune diseases. Frontiers in Immunology, February 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.00270, doi:10.3389/fimmu.2019.00270. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.00270)

[2. (LópezRodríguez2004Loss) Cristina López-Rodríguez, Christopher L. Antos, John M. Shelton, James A. Richardson, Fangming Lin, Tatiana I. Novobrantseva, Roderick T. Bronson, Peter Igarashi, Anjana Rao, and Eric N. Olson. Loss of nfat5 results in renal atrophy and lack of tonicity-responsive gene expression. Proceedings of the National Academy of Sciences, 101(8):2392–2397, February 2004. URL: http://dx.doi.org/10.1073/pnas.0308703100, doi:10.1073/pnas.0308703100. This article has 216 citations.](https://doi.org/10.1073/pnas.0308703100)

[3. (Jiang2019Transcription) Yongsheng Jiang, Ruizhe He, Yuhong Jiang, Dejun Liu, Lingye Tao, Minwei Yang, Chaoyi Lin, Yang Shen, Xueliang Fu, Jianyu Yang, Jiao Li, Yanmiao Huo, Rong Hua, Wei Liu, Junfeng Zhang, Baiyong Shen, Zhigang Zhang, and Yongwei Sun. Transcription factor nfat5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of pgk1. Cell Death &amp; Disease, December 2019. URL: http://dx.doi.org/10.1038/s41419-019-2072-5, doi:10.1038/s41419-019-2072-5. This article has 48 citations.](https://doi.org/10.1038/s41419-019-2072-5)

[4. (Timucin2021Structure) Ahmet Can Timucin. Structure based peptide design, molecular dynamics and mm-pbsa studies for targeting c terminal dimerization of nfat5 dna binding domain. Journal of Molecular Graphics and Modelling, 103:107804, March 2021. URL: http://dx.doi.org/10.1016/j.jmgm.2020.107804, doi:10.1016/j.jmgm.2020.107804. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jmgm.2020.107804)

[5. (DuMond2016Peptide) Jenna F. DuMond, Kevin Ramkissoon, Xue Zhang, Yuichiro Izumi, Xujing Wang, Koji Eguchi, Shouguo Gao, Masashi Mukoyama, Maurice B. Burg, and Joan D. Ferraris. Peptide affinity analysis of proteins that bind to an unstructured nh2-terminal region of the osmoprotective transcription factor nfat5. Physiological Genomics, 48(4):290–305, April 2016. URL: http://dx.doi.org/10.1152/physiolgenomics.00110.2015, doi:10.1152/physiolgenomics.00110.2015. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/physiolgenomics.00110.2015)

[6. (Aramburu2019Regulation) Jose Aramburu and Cristina López-Rodríguez. Regulation of inflammatory functions of macrophages and t lymphocytes by nfat5. Frontiers in Immunology, March 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.00535, doi:10.3389/fimmu.2019.00535. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.00535)

[7. (Jang2012TAZ) Eun Jung Jang, Hana Jeong, Ki Hwan Han, Hyug Moo Kwon, Jeong-Ho Hong, and Eun Sook Hwang. Taz suppresses nfat5 activity through tyrosine phosphorylation. Molecular and Cellular Biology, 32(24):4925–4932, December 2012. URL: http://dx.doi.org/10.1128/MCB.00392-12, doi:10.1128/mcb.00392-12. This article has 69 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00392-12)

[8. (López-Rodríguez1999NFAT5) Cristina López-Rodríguez, José Aramburu, Andrew S. Rakeman, and Anjana Rao. Nfat5, a constitutively nuclear nfat protein that does not cooperate with fos and jun. Proceedings of the National Academy of Sciences, 96(13):7214–7219, June 1999. URL: http://dx.doi.org/10.1073/pnas.96.13.7214, doi:10.1073/pnas.96.13.7214. This article has 298 citations.](https://doi.org/10.1073/pnas.96.13.7214)

[9. (Zhao2021NFAT5Mediated) Guangze Zhao, Sana Aghakeshmiri, Yankuan T. Chen, Huifang M. Zhang, Fione Yip, and Decheng Yang. Nfat5-mediated signalling pathways in viral infection and cardiovascular dysfunction. International Journal of Molecular Sciences, 22(9):4872, May 2021. URL: http://dx.doi.org/10.3390/ijms22094872, doi:10.3390/ijms22094872. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22094872)

[10. (Neuhofer2010Role) Wolfgang Neuhofer. Role of nfat5 in inflammatory disorders associated with osmotic stress. Current Genomics, 11(8):584–590, December 2010. URL: http://dx.doi.org/10.2174/138920210793360961, doi:10.2174/138920210793360961. This article has 96 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/138920210793360961)

[11. (Gallazzini2010c‐Abl) Morgan Gallazzini, Ming‐Jiun Yu, Ruwan Gunaratne, Maurice B. Burg, and Joan D. Ferraris. C‐abl mediates high nacl‐induced phosphorylation and activation of the transcription factor tonebp/orebp. The FASEB Journal, 24(11):4325–4335, June 2010. URL: http://dx.doi.org/10.1096/fj.10-157362, doi:10.1096/fj.10-157362. This article has 30 citations.](https://doi.org/10.1096/fj.10-157362)

[12. (Brown2020Recurrent) Taylor C Brown, Norman G Nicolson, Jianliang Man, Courtney E Gibson, Adam Stenman, C Christofer Juhlin, Reju Korah, and Tobias Carling. Recurrent amplification of the osmotic stress transcription factor nfat5 in adrenocortical carcinoma. Journal of the Endocrine Society, May 2020. URL: http://dx.doi.org/10.1210/jendso/bvaa060, doi:10.1210/jendso/bvaa060. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1210/jendso/bvaa060)

[13. (Kumar2020NFAT5) Raj Kumar, Jenna F. DuMond, Shagufta H. Khan, E. Brad Thompson, Yi He, Maurice B. Burg, and Joan D. Ferraris. Nfat5, which protects against hypertonicity, is activated by that stress via structuring of its intrinsically disordered domain. Proceedings of the National Academy of Sciences, 117(33):20292–20297, August 2020. URL: http://dx.doi.org/10.1073/pnas.1911680117, doi:10.1073/pnas.1911680117. This article has 15 citations.](https://doi.org/10.1073/pnas.1911680117)